Lung cancer screening: the time is now
11 NOVEMBER 2021
Targeted screening can reduce the public health toll of lung cancer and improve quality of life. As November is Lung Cancer Awareness Month (#LCAM) we make the case for implementation of targeted screening programmes.
Lung cancer causes more deaths than any other cancer in Europe. It also costs more, and accounts for one quarter of productivity losses due to premature mortality from cancer. But in early 2020, the landmark NELSON trial published compelling findings that targeted screening using low-dose computed tomography could reduce mortality in lung cancer by up to a quarter.
Read the full blog post here: https://www.healthpolicypartnership.com/lung-cancer-screening-the-time-is-now/
About the authors of this article:
Aoife McNamara is Information Development Manager with the Irish Cancer Society based in Dublin, and a member of the Steering Committee of the GLCC.
Suzanne Wait is Managing Director of the Health Policy Partnership, a specialist health policy research organisation based in London.
This article is also included within the Journal Papers section of the Screening microsite here.
